S-Bank Fund Management’s Royalty Pharma RPRX Stock Holding History

S-Bank Fund Management’s Portfolio RPRX Stock Details RPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$413K	Sell	7,365 -22,497	-75%	-$1.17M	0.06%	169
2026 Q1	$1.43M	Sell	29,862 -1,110	-4%	-$48.6K	0.21%	79
2025 Q4	$1.2M	Sell	30,972 -11,977	-28%	-$457K	0.16%	83
2025 Q3	$1.52M	Sell	42,949 -559	-1%	-$20.2K	0.2%	82
2025 Q2	$1.57M	Buy	+43,508	New	+$1.44M	0.23%	83

Other funds holding RPRX

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

S-Bank Fund Management's RPRX Position: Q2 2026 in Review

S-Bank Fund Management reduced its Royalty Pharma (RPRX) stake by 75% in Q2 2026, selling an estimated $1.17M and leaving 7,365 shares worth $413K. The position accounts for 0.06% of the portfolio, ranked #169.

S-Bank Fund Management first reported a position in RPRX in Q2 2025 and has held it in 5 quarters since. The position peaked at $1.57M in Q2 2025. 647 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

S-Bank Fund Management held 7,365 shares of Royalty Pharma worth $413K as of Q2 2026.
S-Bank Fund Management sold 22,497 Royalty Pharma shares in Q2 2026, an estimated $1.17M.
Royalty Pharma made up 0.06% of S-Bank Fund Management's portfolio in Q2 2026, its #169 holding.
S-Bank Fund Management first reported a position in Royalty Pharma in Q2 2025 and has held it in 5 quarters since.
S-Bank Fund Management's Royalty Pharma position peaked at $1.57M in Q2 2025.
647 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on S-Bank Fund Management's 13F filing for Q2 2026, filed 4 Aug 2026.